PL3797774T3 - Rebamipid do zastosowania w zapobieganiu i/lub leczeniu sztywności tętnic - Google Patents
Rebamipid do zastosowania w zapobieganiu i/lub leczeniu sztywności tętnicInfo
- Publication number
- PL3797774T3 PL3797774T3 PL19020528.6T PL19020528T PL3797774T3 PL 3797774 T3 PL3797774 T3 PL 3797774T3 PL 19020528 T PL19020528 T PL 19020528T PL 3797774 T3 PL3797774 T3 PL 3797774T3
- Authority
- PL
- Poland
- Prior art keywords
- rebamipide
- prevention
- treatment
- arterial stiffness
- arterial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19020528.6A EP3797774B1 (en) | 2019-09-11 | 2019-09-11 | Rebamipide for use in prevention and/or treatment of arterial stiffness |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3797774T3 true PL3797774T3 (pl) | 2025-05-12 |
Family
ID=67956439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19020528.6T PL3797774T3 (pl) | 2019-09-11 | 2019-09-11 | Rebamipid do zastosowania w zapobieganiu i/lub leczeniu sztywności tętnic |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220304999A1 (pl) |
| EP (1) | EP3797774B1 (pl) |
| JP (1) | JP7692896B2 (pl) |
| KR (1) | KR20220062008A (pl) |
| CN (1) | CN114340627A (pl) |
| AU (1) | AU2020347481A1 (pl) |
| BR (1) | BR112022003917A2 (pl) |
| CA (1) | CA3152961A1 (pl) |
| ES (1) | ES3018293T3 (pl) |
| MX (1) | MX2022002993A (pl) |
| PL (1) | PL3797774T3 (pl) |
| WO (1) | WO2021048314A1 (pl) |
| ZA (1) | ZA202203554B (pl) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008015959A1 (en) * | 2006-08-01 | 2008-02-07 | Otsuka Pharmaceutical Co., Ltd. | Pharmaceutical composition improved in absorption of pharmacologically active substance |
| JP2011184429A (ja) * | 2010-02-10 | 2011-09-22 | Univ Of Tsukuba | 低分子抗酸化剤及び高分子化環状ニトロキシドラジカル化合物を含む組成物 |
| JP6023328B2 (ja) * | 2012-07-31 | 2016-11-09 | ザ カトリック ユニバーシティ オブ コリア インダストリー−アカデミック コーオペレイション ファウンデーション | レバミピドを有効成分として含む高脂血症及びこれと関連した疾患の予防または治療用組成物 |
-
2019
- 2019-09-11 EP EP19020528.6A patent/EP3797774B1/en active Active
- 2019-09-11 PL PL19020528.6T patent/PL3797774T3/pl unknown
- 2019-09-11 ES ES19020528T patent/ES3018293T3/es active Active
-
2020
- 2020-09-10 CA CA3152961A patent/CA3152961A1/en active Pending
- 2020-09-10 US US17/638,873 patent/US20220304999A1/en active Pending
- 2020-09-10 JP JP2022513873A patent/JP7692896B2/ja active Active
- 2020-09-10 CN CN202080061701.XA patent/CN114340627A/zh active Pending
- 2020-09-10 KR KR1020227010812A patent/KR20220062008A/ko not_active Ceased
- 2020-09-10 WO PCT/EP2020/075399 patent/WO2021048314A1/en not_active Ceased
- 2020-09-10 BR BR112022003917A patent/BR112022003917A2/pt not_active Application Discontinuation
- 2020-09-10 MX MX2022002993A patent/MX2022002993A/es unknown
- 2020-09-10 AU AU2020347481A patent/AU2020347481A1/en not_active Abandoned
-
2022
- 2022-03-25 ZA ZA2022/03554A patent/ZA202203554B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3152961A1 (en) | 2021-03-18 |
| EP3797774B1 (en) | 2024-12-25 |
| BR112022003917A2 (pt) | 2022-05-31 |
| AU2020347481A1 (en) | 2022-04-21 |
| WO2021048314A1 (en) | 2021-03-18 |
| ZA202203554B (en) | 2023-11-29 |
| MX2022002993A (es) | 2022-06-08 |
| KR20220062008A (ko) | 2022-05-13 |
| JP7692896B2 (ja) | 2025-06-16 |
| EP3797774A1 (en) | 2021-03-31 |
| US20220304999A1 (en) | 2022-09-29 |
| ES3018293T3 (en) | 2025-05-14 |
| JP2022549770A (ja) | 2022-11-29 |
| CN114340627A (zh) | 2022-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202307970B (en) | Compounds for use in the treatment and prevention of covid- 19 | |
| ES3064839T3 (en) | Combination of cannabidiol and buprenorphine and its use for the treatment of chronic pain | |
| IL289758B2 (en) | Proportin inhibitors for use in the prevention and treatment of kidney injury | |
| IL286697A (en) | Neurogulin-4 compounds and methods of use | |
| EP4640237A3 (en) | Macrophage-based therapy for use in the treatment of acute liver injury | |
| IL269083A (en) | Methods for preventing and treating heart disease | |
| IL270976A (en) | IL-8 inhibitors for use in the treatment and/or prevention of secondary bacterial infection | |
| PT4031117T (pt) | Mutante do ngf para utilização no tratamento ou prevenção de distúrbios oftálmicos | |
| IL280868A (en) | Preparations and methods for the treatment of acute lung injury | |
| GB201802864D0 (en) | Prevention or treatment of cardiac arrhytmia and sudden cardiac death | |
| PL3741370T3 (pl) | Rebamipid do zastosowania w profilaktyce synukleinopatii | |
| GB201801694D0 (en) | Methods for assessing risk of cardiovascular disease and methods and compounds for use in treating or preventing cardiovascular disease | |
| PT3937949T (pt) | Fitoecdisonas e seus derivados para utilização no tratamento da alteração da função respiratória | |
| PL3797774T3 (pl) | Rebamipid do zastosowania w zapobieganiu i/lub leczeniu sztywności tętnic | |
| PL3797771T3 (pl) | Rebamipid do stosowania w zapobieganiu i leczeniu celiakii | |
| ZA201906964B (en) | Prevention and/or treatment of inflammatory skin disease | |
| PL3797772T3 (pl) | Rebamipid do zastosowania w zapobieganiu i leczeniu choroby Leśniowskiego-Crohna | |
| IL312428A (en) | Use of Maribavir for treatment and their treatment methods | |
| PL3654932T3 (pl) | Tyrotrycyna do zastosowania w leczeniu lub profilaktyce zapachu ciała oraz preparaty do tego zastosowania | |
| IL311266A (en) | Compositions and methods for treating or preventing autoimmune diseases | |
| PT3595660T (pt) | Compostos para utilização na prevenção e/ou tratamento de doença do fígado gordo não-alcoólico e esteato-hepatite nãoalcoólica | |
| IL284298A (en) | Compounds for use as therapeutically active substances in the treatment and/or prevention of neuroretinal diseases | |
| GB2610895C (en) | Composition for use in the treatment and/or prevention of mycotoxic disease | |
| IL270306A (en) | Prevention and treatment of pre-myeloid and myeloid malignancies | |
| IL268860A (en) | Granzyme B inhibitor preparations and methods for preventing and/or treating blistered and/or peeling skin |